---
title: OI Prophylaxis-HIV AIDS
---
# OI Prophylaxis-HIV AIDS

 (https://aidsinfo.nih.gov/guidelines & JAMA 2018;320:379, HIV.gov:2020)
OI Indication 1° Prophylaxis
## Tuberculosis
⊕ PPD (≥5 mm), IGRA, or high-risk exposure
See treatment for latent TB
## Pneumocystis jiroveci (PCP)
CD4 <200/mm or CD4 <14% or thrush
TMP-SMX DS qd (first line) or dapsone qd or atovaquone qd or pentamidine inhaled q4wk
## Histoplasmosis
CD4 <150/mm + endemic/ exposure
Itraconazole qd
## Toxoplasmosis
CD4 <100/mm3 and ⊕ Toxo IgG
TMP-SMX DS qd or dapsone 50 mg qd + pyrimeth. qwk + leucovorin 25 qwk
## MAC
Ppx no longer rec. if effective ARVs initiated

When to stop Ppx: PCP and toxo if CD4 >200 × 3 mos; Histo if CD4 >150 × 6 mos
